{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,22]],"date-time":"2026-02-22T03:07:32Z","timestamp":1771729652142,"version":"3.50.1"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100001502","name":"Blue Cross Blue Shield of Michigan Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001502","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","thrombosisresearch.com","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.thromres.2024.109239","type":"journal-article","created":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T16:50:46Z","timestamp":1733331046000},"page":"109239","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Prevalence of discussions around left atrial appendage occlusion as a treatment option in patients on oral anticoagulation experiencing a major bleeding event"],"prefix":"10.1016","volume":"245","author":[{"given":"Amber","family":"Co","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chloe","family":"Kazaglis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah","family":"DeCamillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Haymart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brindha","family":"Rajakumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geoffrey D.","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.thromres.2024.109239_bb0005","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s11606-019-05391-y","article-title":"Emergency visits for oral anticoagulant bleeding","volume":"35","author":"Geller","year":"2020","journal-title":"J. Gen. Intern. Med."},{"issue":"10","key":"10.1016\/j.thromres.2024.109239_bb0010","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1111\/jth.15476","article-title":"Recurrent bleeding and thrombotic events after resumption of oral anticoagulants following gastrointestinal bleeding: communication from the ISTH SSC subcommittee on control of anticoagulation","volume":"19","author":"Candeloro","year":"2021","journal-title":"J. Thromb. Haemost."},{"issue":"3","key":"10.1016\/j.thromres.2024.109239_bb0015","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1080\/08998280.2022.2043707","article-title":"Management dilemmas in restarting anticoagulation after gastrointestinal bleeding","volume":"35","author":"Jain","year":"2022","journal-title":"Proc. (Baylor Univ. Med. Cent.)"},{"issue":"4","key":"10.1016\/j.thromres.2024.109239_bb0020","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s40256-023-00582-9","article-title":"Management of gastrointestinal bleeding and resumption of oral anticoagulant therapy in patients with atrial fibrillation: a multidisciplinary discussion","volume":"23","author":"Martin","year":"2023","journal-title":"Am. J. Cardiovasc. Drugs"},{"issue":"1","key":"10.1016\/j.thromres.2024.109239_bb0025","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","article-title":"2023 ACC\/AHA\/ACCP\/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"149","author":"Joglar","year":"2024","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.thromres.2024.109239_bb0030","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s11239-012-0766-y","article-title":"Use of warfarin for venous thromboembolism prophylaxis following knee and hip arthroplasty: results of the Michigan anticoagulation quality improvement initiative (MAQI2)","volume":"35","author":"Barnes","year":"2013","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.thromres.2024.109239_bb0035","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients","volume":"3","author":"Schulman","year":"2005","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2024.109239_bb0040","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jbi.2015.05.003","article-title":"Supporting information retrieval from electronic health records: a report of University of Michigan\u2019s nine-year experience in developing and using the electronic medical record search engine (EMERSE)","volume":"55","author":"Hanauer","year":"2015","journal-title":"J. Biomed. Inform."},{"issue":"1","key":"10.1016\/j.thromres.2024.109239_bb0045","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1161\/STROKEAHA.123.040447","article-title":"Stroke prevention in atrial fibrillation: our current failures and required research","volume":"55","author":"Gurol","year":"2024","journal-title":"Stroke"},{"key":"10.1016\/j.thromres.2024.109239_bb0050","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ahj.2023.07.013","article-title":"Physicians\u2019 perspectives on percutaneous left atrial appendage occlusion for patients with atrial fibrillation","volume":"266","author":"Kir","year":"2023","journal-title":"Am. Heart J."},{"issue":"13","key":"10.1016\/j.thromres.2024.109239_bb0055","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/j.jacc.2019.12.040","article-title":"The NCDR left atrial appendage occlusion registry","volume":"75","author":"Freeman","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"issue":"10","key":"10.1016\/j.thromres.2024.109239_bb0060","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1001\/jamacardio.2024.2335","article-title":"Low-dose direct oral anticoagulation vs dual antiplatelet therapy after left atrial appendage occlusion: the ADALA randomized clinical trial","volume":"9","author":"Freixa","year":"2024","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.thromres.2024.109239_bb0065","author":"Anticoagulation Forum"},{"issue":"3","key":"10.1016\/j.thromres.2024.109239_bb0070","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1177\/08971900211064189","article-title":"Anticoagulation changes following major and clinically relevant nonmajor bleeding events in non-valvular atrial fibrillation patients","volume":"36","author":"Feldeisen","year":"2023","journal-title":"J. Pharm. Pract."},{"issue":"12","key":"10.1016\/j.thromres.2024.109239_bb0075","doi-asserted-by":"crossref","first-page":"e006391","DOI":"10.1161\/JAHA.117.006391","article-title":"Therapeutic strategies following major, clinically relevant nonmajor, and nuisance bleeding in atrial fibrillation: findings from ORBIT-AF","volume":"7","author":"O\u2019Brien","year":"2018","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.thromres.2024.109239_bb0080","doi-asserted-by":"crossref","unstructured":"Paquette M, Franca LR, Teutsch C, Diener HC, Lu S, Dubner SJ, Ma CS, Rothman KJ, Zint K, Halperin JL,et al. Dabigatran persistence and outcomes following discontinuation in atrial fibrillation patients from the GLORIA-AF registry. Am. J. Cardiol. 2020 Feb 1;125(3):383\u2013391. doi: https:\/\/doi.org\/10.1016\/j.amjcard.2019.10.047. Epub 2019 Nov 7. PMID: 31785775.","DOI":"10.1016\/j.amjcard.2019.10.047"},{"key":"10.1016\/j.thromres.2024.109239_bb0085","doi-asserted-by":"crossref","unstructured":"Lip GYH, Banerjee A, Boriani G, Chiang CE, Fargo R, Freedman B, Lane DA, Ruff CT, Turakhia M, Werring D, et al. Antithrombotic therapy for atrial fibrillation: CHEST guideline and expert panel report. Chest 2018 Nov;154(5):1121\u20131201. doi: https:\/\/doi.org\/10.1016\/j.chest.2018.07.040. Epub 2018 Aug 22. PMID: 30144419.","DOI":"10.1016\/j.chest.2018.07.040"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384824003712?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384824003712?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T18:33:35Z","timestamp":1735238015000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384824003712"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":17,"alternative-id":["S0049384824003712"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2024.109239","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence of discussions around left atrial appendage occlusion as a treatment option in patients on oral anticoagulation experiencing a major bleeding event","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2024.109239","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109239"}}